Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-24 @ 6:49 PM
NCT ID:
NCT02623257
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed stage IIIB/IV NSCLC;
* Patient had received ≤ 1 prior systemic chemotherapy regimens;
* Provision of blood (plasma) sample for ctDNA testing;
* Patient must be able to comply with the protocol;
Exclusion Criteria:
* Prior received ≥2 systemic chemotherapy regimens;
* As judged by the investigator, any evidence of severe or uncontrolled systemic disease (e.g. unstable or uncompensated respiratory, cardiac, hepatic or renal disease);
* Histologically confirmed small cell lung cancer or other metastatic tumors;
* Patient with no histologic or cytological diagnosis;
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02623257
Study Brief:
Protocol Section:
NCT02623257